Circulating tumour cell analysis to predict efficacy of Eribulin for metastatic breast cancer patients

被引：0
|
作者：
Horimoto, Yoshiya [1 ]
Murakami, Fumi [1 ]
Saito, Mitsue [1 ]
机构：
[1] Juntendo Univ, Sch Med, Dept Breast Oncol, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2072
引用
收藏
页码：664 / 664
页数：1
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF ERIBULIN IN PATIENTS WITH TRIPLE NEGATIVE METASTATIC BREAST CANCER: REAL LIFE EXPERIENCE
    Valentinova, Ludmila Manzyuk
    BREAST, 2017, 36 : S57 - S58
  • [32] Efficacy and safety of eribulin in patients with triple negative metastatic breast cancer: real life experience
    Manikhas, A.
    Gorbunova, V.
    Manzyuk, L.
    Kovalenko, E.
    Bolotina, L.
    Zhukova, L.
    Vladimirova, L.
    Kolyadina, I.
    Ponomarenko, D.
    Mukhametshina, G.
    BREAST, 2019, 44 : S61 - S62
  • [33] Impact of absolute lymphocyte count on the efficacy of eribulin and capecitabine in patients with metastatic breast cancer.
    Ueno, Ayako
    Maeda, Reina
    Kim, Kyeongduk
    Ito, Mitsuya
    Kawasaki, Kensuke
    Ohtani, Shoichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] MONITORING OF METASTATIC BREAST CANCER USING CIRCULATING TUMOUR DNA: A COMPARISON WITH CIRCULATING TUMOUR CELLS
    Dawson, S.
    Tsui, D.
    Murtaza, M.
    Biggs, H.
    Chin, S.
    Gale, D.
    Forshew, T.
    Wallis, M.
    Rosenfeld, N.
    Caldas, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 74 - 74
  • [35] Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies
    Twelves, Chris
    Cortes, Javier
    Vahdat, Linda
    Olivo, Martin
    He, Yi
    Kaufman, Peter A.
    Awada, Ahmad
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) : 553 - 561
  • [36] Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients
    De Sanctis, Rita
    Agostinetto, Elisa
    Masci, Giovanna
    Ferraro, Emanuela
    Losurdo, Agnese
    Vigano, Alessandro
    Antunovic, Lidija
    Zuradelli, Monica
    Torrisi, Rosalba Maria Concetta
    Santoro, Armando
    ONCOLOGY, 2018, 94 : 19 - 28
  • [37] Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies
    Chris Twelves
    Javier Cortes
    Linda Vahdat
    Martin Olivo
    Yi He
    Peter A. Kaufman
    Ahmad Awada
    Breast Cancer Research and Treatment, 2014, 148 : 553 - 561
  • [38] Efficacy it eribulin in patients (pts) with metastatic breast cancer (MBC): A pooled Analysis by HER2 and ER status
    Kaufman, Peter
    Twelves, Chris
    Cortes, Javier
    Vandat, Linda T.
    Olivo, Martin
    He, Yi
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [39] Metronomic eribulin in metastatic breast cancer
    Chalasani, Pavani
    Robert, Livingston B.
    Rado, Thomas A.
    Gadi, Vijayakrishna K.
    Kummet, Thomas D.
    Specht, Jennifer M.
    Stopeck, Alison
    Linden, Hannah M.
    CANCER RESEARCH, 2015, 75
  • [40] Efficacy of eribulin in patients (pts) with metastatic breast cancer (MBC): a pooled analysis by HER2 and ER status
    Twelves, C.
    Cortes, J.
    Vahdat, L.
    Olivo, M.
    He, Y.
    Kaufman, P. A.
    Awada, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 261 - 262
12345